March 30, 2018
Accolade announced $50 million in funding led by existing investors Andreessen Horowitz, Carrick Capital Partners, Madrona Venture Group and McKesson Ventures, with participation from new investors including Cross Creek Advisors and Madera Technology Partners.
MedCity reveals how Accolade has grown since its last financing round:
- Expanded customer base to enterprise segment
- Unveiled Maya intelligence engine for personalized health and benefits recommendations
- Developed new products such as Accolade IQ and Mobile